March 24, 2020 / 10:13 PM / 6 days ago

BRIEF-Akers Biosciences Schedules Conference Call To Discuss Licensing Announcement With Premas Biotech For A Coronvirus Vaccine Candidate

March 24 (Reuters) - Akers Biosciences Inc:

* AKERS BIOSCIENCES SCHEDULES CONFERENCE CALL TO DISCUSS LICENSING ANNOUNCEMENT WITH PREMAS BIOTECH FOR A CORONVIRUS VACCINE CANDIDATE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below